These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 28974543)
21. Propranolol reduces IFN-γ driven PD-L1 immunosuppression and improves anti-tumour immunity in ovarian cancer. Falcinelli M; Al-Hity G; Baron S; Mampay M; Allen MC; Samuels M; Jones W; Cilibrasi C; Flaherty RL; Giamas G; Thaker PH; Flint MS Brain Behav Immun; 2023 May; 110():1-12. PubMed ID: 36796704 [TBL] [Abstract][Full Text] [Related]
22. Interferon-gamma increases monocyte PD-L1 but does not diminish T-cell activation. Galbraith NJ; Walker SP; Gardner SA; Bishop C; Galandiuk S; Polk HC Cell Immunol; 2020 Nov; 357():104197. PubMed ID: 32891037 [TBL] [Abstract][Full Text] [Related]
23. Splenic T lymphocytes induce the formation of immunosuppressive neutrophils through IFN-γ in sepsis. Huang J; Sun R; Yang Y; Li L; Liu L; Shao Y; Ji D; Sun B Inflamm Res; 2022 Jan; 71(1):81-91. PubMed ID: 34841450 [TBL] [Abstract][Full Text] [Related]
24. da Fonseca-Martins AM; de Souza Lima-Gomes P; Antunes MM; de Moura RG; Covre LP; Calôba C; Rocha VG; Pereira RM; Menezes GB; Gomes DCO; Saraiva EM; de Matos Guedes HL Front Immunol; 2021; 12():598943. PubMed ID: 34211455 [TBL] [Abstract][Full Text] [Related]
25. [Effect of autophagy on expression of neutrophil programmed death ligand-1 in mice with sepsis]. Huang J; Sun R; Qi X; Liu L; Yang Y; Sun B Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Sep; 31(9):1091-1096. PubMed ID: 31657331 [TBL] [Abstract][Full Text] [Related]
26. IFN-gamma-independent production of IL-12 during murine endotoxemia. Heinzel FP; Rerko RM; Ahmed F; Hujer AM J Immunol; 1996 Nov; 157(10):4521-8. PubMed ID: 8906830 [TBL] [Abstract][Full Text] [Related]
27. Regulation of PD-L1 expression on murine tumor-associated monocytes and macrophages by locally produced TNF-α. Hartley G; Regan D; Guth A; Dow S Cancer Immunol Immunother; 2017 Apr; 66(4):523-535. PubMed ID: 28184968 [TBL] [Abstract][Full Text] [Related]
28. α-PD-L1 mAb enhances the abscopal effect of hypo-fractionated radiation by attenuating PD-L1 expression and inducing CD8 Wang H; Lin X; Luo Y; Sun S; Tian X; Sun Y; Zhang S; Chen J; Zhang J; Liu X; Liu H; Gong Y; Xie C Immunotherapy; 2019 Feb; 11(2):101-118. PubMed ID: 30511887 [TBL] [Abstract][Full Text] [Related]
29. L-5-hydroxytryptophan promotes antitumor immunity by inhibiting PD-L1 inducible expression. Huang J; Wang X; Li B; Shen S; Wang R; Tao H; Hu J; Yu J; Jiang H; Chen K; Luo C; Dang Y; Zhang Y J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35728870 [TBL] [Abstract][Full Text] [Related]
30. IFN-γ-induced PD-L1 expression on human melanocytes is impaired in vitiligo. Willemsen M; Krebbers G; Tjin EPM; Willemsen KJ; Louis A; Konijn VAL; Narayan VS; Post NF; Bakker WJ; Melief CJM; Bekkenk MW; Luiten RM Exp Dermatol; 2022 Apr; 31(4):556-566. PubMed ID: 34758170 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of PI3Kδ Enhances Poly I:C-Induced Antiviral Responses and Inhibits Replication of Human Metapneumovirus in Murine Lungs and Human Bronchial Epithelial Cells. Fujita A; Kan-O K; Tonai K; Yamamoto N; Ogawa T; Fukuyama S; Nakanishi Y; Matsumoto K Front Immunol; 2020; 11():432. PubMed ID: 32218789 [TBL] [Abstract][Full Text] [Related]
32. Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway. Wang TT; Zhao YL; Peng LS; Chen N; Chen W; Lv YP; Mao FY; Zhang JY; Cheng P; Teng YS; Fu XL; Yu PW; Guo G; Luo P; Zhuang Y; Zou QM Gut; 2017 Nov; 66(11):1900-1911. PubMed ID: 28274999 [TBL] [Abstract][Full Text] [Related]
33. PD-L1 engagement on T cells promotes self-tolerance and suppression of neighboring macrophages and effector T cells in cancer. Diskin B; Adam S; Cassini MF; Sanchez G; Liria M; Aykut B; Buttar C; Li E; Sundberg B; Salas RD; Chen R; Wang J; Kim M; Farooq MS; Nguy S; Fedele C; Tang KH; Chen T; Wang W; Hundeyin M; Rossi JAK; Kurz E; Haq MIU; Karlen J; Kruger E; Sekendiz Z; Wu D; Shadaloey SAA; Baptiste G; Werba G; Selvaraj S; Loomis C; Wong KK; Leinwand J; Miller G Nat Immunol; 2020 Apr; 21(4):442-454. PubMed ID: 32152508 [TBL] [Abstract][Full Text] [Related]
34. Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy. Liu Z; Ravindranathan R; Kalinski P; Guo ZS; Bartlett DL Nat Commun; 2017 Mar; 8():14754. PubMed ID: 28345650 [TBL] [Abstract][Full Text] [Related]
35. CD169 Shaabani N; Duhan V; Khairnar V; Gassa A; Ferrer-Tur R; Häussinger D; Recher M; Zelinskyy G; Liu J; Dittmer U; Trilling M; Scheu S; Hardt C; Lang PA; Honke N; Lang KS Cell Death Dis; 2016 Nov; 7(11):e2446. PubMed ID: 27809306 [TBL] [Abstract][Full Text] [Related]
36. Increased expression of PD-L1 and PD-L2 in dermal fibroblasts from alopecia areata mice. Li Y; Kilani RT; Pakyari M; Leung G; Nabai L; Ghahary A J Cell Physiol; 2018 Mar; 233(3):2590-2601. PubMed ID: 28777458 [TBL] [Abstract][Full Text] [Related]
37. PD-L1 overexpression conveys tolerance of mesenchymal stem cell-derived cardiomyocyte-like cells in an allogeneic mouse model. Mardomi A; Limoni SK; Rahbarghazi R; Mohammadi N; Khorashadizadeh M; Ranjbaran H; Nataj HH; Jafari N; Hasani B; Abediankenari S J Cell Physiol; 2021 Sep; 236(9):6328-6343. PubMed ID: 33507552 [TBL] [Abstract][Full Text] [Related]
38. Increase of cells expressing PD-1 and PD-L1 and enhancement of IFN-γ production via PD-1/PD-L1 blockade in bovine mycoplasmosis. Goto S; Konnai S; Okagawa T; Nishimori A; Maekawa N; Gondaira S; Higuchi H; Koiwa M; Tajima M; Kohara J; Ogasawara S; Kato Y; Suzuki Y; Murata S; Ohashi K Immun Inflamm Dis; 2017 Sep; 5(3):355-363. PubMed ID: 28544524 [TBL] [Abstract][Full Text] [Related]
39. MYC inhibition increases PD-L1 expression induced by IFN-γ in hepatocellular carcinoma cells. Zou J; Zhuang M; Yu X; Li N; Mao R; Wang Z; Wang J; Wang X; Zhou H; Zhang L; Shi Y Mol Immunol; 2018 Sep; 101():203-209. PubMed ID: 30007230 [TBL] [Abstract][Full Text] [Related]
40. High macrophage PD-L1 expression not responsible for T cell suppression. Goldman N; Lomakova YD; Londregan J; Bucknum A; DePierri K; Somerville J; Riggs JE Cell Immunol; 2018 Feb; 324():50-58. PubMed ID: 29305065 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]